- Biologics manufacturing facility majority deploys single-use and state-of-the-art equipments from reputed companies. It is also built and operated to comply with the cGMP standards of various regulatory agencies.
- State-of-the-art facility has been successfully audited and inspected by WHO-GMP and PIC/S member countries viz SMDC-Ukraine, NPRA-Malaysia, TMMDA-Turkey, TFDA-Thailand, COFEPRIS - Mexico, ANMAT - Argentina.
- Also approved by INVIMA - Colombia, ISP - Chile, PPB - Kenya, NMRA - Srilanka, FDA - Tanzania, FDA - Philippines, DDA - Nepal, FMHACA - Ethiopia, NAFDAC - Nigeria, DIGEMID - Peru , NDA - Uganda, ZaZiBoNa, MoH - Syria and other agencies.
- Fully integrated facility with best in class single-use process systems in both upstream and downstream.
- Manufacturing facility for both drug substance and drug product with enough capacity to manufacture and cater to large markets, with ample scope for expansion.